David Linetsky - Apr 18, 2024 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role: SVP, Life Sciences
Signature: /s/ Allison Hoffman by Power of Attorney for David Linetsky
Stock symbol: PHR
Transactions as of: Apr 18, 2024
Transactions value $: -$6,146
Form type: 4
Date filed: 4/19/2024, 04:24 PM
Previous filing: Apr 17, 2024
Next filing: Jun 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHR	Common Stock	Sale	-$6.15K	-269	-3.66%	$22.85	7.09K	Apr 18, 2024	By Spouse	F1, F2
holding	PHR	Common Stock						204K	Apr 18, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.56 to $23.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.56 to $23.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.